Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Dr. Reddy's Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (RDY)
12.67 +0.09 (+0.72%) 12:48 ET [NYSE]
12.65 x 100 12.66 x 300
Realtime by (Cboe BZX)
12.65 x 100 12.66 x 300
Realtime - - (-) -
Profile for Tue, Apr 8th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Dr. Reddy's Laboratories Ltd ADR 8-2-337 ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 IND

www.drreddys.com Employees: 27,048 P: 91-40-4900-2900 F: 404-900-2999

Sector:

Medical

Description:

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.

Key Statistics

Overview:

Market Capitalization, $K 10,501,431
Enterprise Value, $K 10,657,431
Shares Outstanding, K 834,772
Annual Sales, $ 3,350 M
Annual Net Income, $ 668,000 K
Last Quarter Sales, $ 986,310 K
Last Quarter Net Income, $ 166,770 K
EBIT, $ 819,500 K
EBITDA, $ 997,500 K
60-Month Beta 0.51
% of Insider Shareholders 2.00%
% of Institutional Shareholders 3.85%
Float, K 818,077
% Float 98.00%
Short Volume Ratio 0.72

Growth:

1-Year Return -13.84%
3-Year Return 12.30%
5-Year Return 23.33%
5-Year Revenue Growth 50.56%
5-Year Earnings Growth 142.42%
5-Year Dividend Growth 60.00%

Per-Share Information:

Most Recent Earnings 0.20 on 01/23/25
Next Earnings Date 05/06/25
Earnings Per Share ttm 0.63
EPS Growth vs. Prev Qtr 400.00%
EPS Growth vs. Prev Year 1.01%
Annual Dividend Rate, $ 0.08
Annual Dividend Yield 0.64%
Most Recent Dividend 0.404 on 07/30/24
Next Ex-Dividends Date 07/30/24
Dividend Payable Date 08/12/24
Dividend Payout Ratio 10.52%
Most Recent Split 5-1 on 11/05/24

RDY Ratios

Ratio
Price/Earnings ttm 19.68
Price/Earnings forward 15.12
Price/Earnings to Growth N/A
Return-on-Equity % 17.87%
Return-on-Assets % 12.32%
Profit Margin % 19.94%
Debt/Equity 0.16
Price/Sales 2.88
Price/Cash Flow 12.19
Price/Book 2.74
Book Value/Share 4.50
Interest Coverage 42.05

RDY Dividends

Date Value
07/30/24 $0.4040
07/28/23 $0.4100
07/07/23 $0.4140
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades